×

收藏-健康网会员访问记录

网页标题:
×

注册健康网用户

用 户 名:
联 系 人:
性  别:
密  码:
重复密码:
电子邮箱:
邮箱验证码:
固定电话:
传  真:
手  机:
单位名称:
通信地址:
首选栏目:
我已经认真阅读并同意《健康网服务条款》
×

找回密码

  • 1.选择找回方式
  • 2.确认验证信息
  • 3.修改密码
  • 4.修改成功
  • 找回方式:
  • 用 户 名:
  • 手机号码:

 您现在位置:健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Alprostadil Market Report

作者:wangchun   来源:本站原创    点击数:0    更新时间:2007-9-11 10:30:38

[关键字]: Chinese medical industry

健康网讯:

Research Report On Chinese Alprostadil Market(2007 Edition)

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published:  April 2007
Format:  Hardcopy and Adobe PDF
Price:  US$ 16,00
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68052505
E-mail: bianch@healthoo.com   wuhf@healthoo.com                     

Table of contents
1 Brief introduce of Alprostadil
  1.1 Development history
  1.2 introduce of clinical uses
  1.3 Production situation of Alprostadil in China
2 Market analysis of Alprostadil
  2.1 Growth trend of Alprostadil from 2002 to 2006
  2.2 Sales values of Alprostadil for different enterprises (brands) from 2002 to 2006
  2.3 Sales shares of Alprostadil for different enterprises (brands) from 2002 to 2006
    2.3.1 Sales shares of different brands
      Beijing
      Shhanghai
      Guangzhou
      Hangzhou
      Nanjing
    2.3.2 Slaes shares of “KaiShi” in different cities from 2002 to 2006
    2.3.3 Slaes shares of “BaoSaXin” in different cities from 2002 to 2006
    2.3.4 Slaes shares of “BoLeSi” in different cities from 2002 to 2006
    2.3.5 Slaes shares of “SaiEr” in different cities from 2002 to 2006
    2.3.6 Slaes shares of “KangPuXi” in different cities from 2002 to 2006
3 Aanlysis on the foumulaions, specifacations and prices
4 Market forcast

Tables and figures
Table 1 List of domestic marketed products and import procucts
Table 2 List of enterprises which are applying the registertion of Sulpiride
Table 3 Sales values in sample hospitals from 2002 to 2006
Table 4 Sales rank of Alprostadil manufacturers in sample hospitals in 2006
Table 5 Sales values of different brands from 2002 to 2006
Table 6 Sales values of Alprostadil in key cities from 2002 to 2006
Table 7 Sales values and shares of “KaiShi” in key cities from 2002 to 2006
Table 8 Sales values and shares of “BaoSaXin” in key cities from 2002 to 2006
Table 9 Sales values and shares of “BoLeSi” in key cities from 2002 to 2006
Table 10 Sales values and shares of “SaiEr” in key cities from 2002 to 2006
Table 11 Sales values and shares of “KangPuXi” in key cities from 2002 to 2006
Table 11 Retail prices

Figure 1 Growth trend from 2002 to 2006
Figure 2 Market shares of different enterprises in 2006
Figure 3 Market shares of different enterprises in 2005
Figure 4 Sales trends of top 5 brands from 2002 to 2006
Figure 5 Sales trends of different brands in Beijing from 2002 to 2006
Figure 6 Sales trends of different brands in Shanghai from 2002 to 2006
Figure 7 Sales trends of different brands in Guangzhou from 2002 to 2006
Figure 8 Sales trends of different brands in Hangzhou from 2002 to 2006
Figure 9 Sales trends of different brands in Nanjing from 2002 to 2006
Figure 10 Sales trend of “KaiShi” from 2002 to 2006
Figure 11 Sales trends of “KaiShi” in 5 cities from 2002 to 2006
Figure 12 Average gorwth of “KaiShi” from 2002 to 2006
Figure 13 Sales trend of “BaoSaXin” from 2002 to 2006
Figure 14 Sales trends of “BaoSaXin” in 5 cities from 2002 to 2006
Figure 15 Average gorwth of “BaoSaXin” from 2002 to 2006
Figure 16 Sales trend of “BoLeSi” from 2002 to 2006
Figure 17 Sales trends of “BoLeSi” in 5 cities from 2002 to 2006
Figure 18 Average gorwth of “BoLeSi” from 2002 to 2006
Figure 19 Sales trend of “SaiEr” from 2002 to 2006
Figure 20 Sales trends of “SaiEr” in 5 cities from 2002 to 2006
Figure 21 Average gorwth of “SaiEr” from 2002 to 2006
Figure 22 Sales trend of  from 2002 to 2006
Figure 23 Sales amounts of Alprostadil with different formulations from 2002 to 2006
Figure 24 Sales values of Alprostadil with different formulations from 2002 to 2006
Figure 25 Sales values of powder for injection with different specifications from 2002 to 2006
Figure 26 Sales amounts of powder for injection with different specifications from 2002 to 2006
Figure 27 Sales values of liposome formulation with different specifications from 2002 to 2006
Figure 28 Sales amounts of liposome formulation with different specifications from 2002 to 2006

Alprostadil Market Report
注册后,我们会为你提供报告样本并为您提供更全面的咨询服务
您的姓名  称谓: 先生女士
手机号码 
电子邮件 
单位名称 

服务热线

  • 联系项目:86-10-68012929-2103
  • 订购报告:86-10-68012929-2103
  • 邮件订购:leigy@healthoo.com